FineHeart named leader of the IPCEI Health Tech4Cure to spearhead the structuring of the European implantable medical device sector
Bordeaux, France – July 24th 2025 – FineHeart, a clinical-stage medical technology company specializing in the development of innovative solutions for cardiology, has been designated as the lead partner of the IPCEI Tech4Cure (Important Project of Common European Interest), dedicated to the implantable medical device (IMD) sector. This project isjointly notified by six EU Member States – France, Hungary, Italy, Latvia, Slovakia, and Slovenia –